Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- Check3 days agoChange DetectedRevision history updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedA minor site maintenance update adds Revision: v3.3.3 and removes older notes; this does not affect trial data or the public record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.3.2 appears in the page history, replacing Revision: v3.3.1 in the footer.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision v3.3.1 was added to the page history, replacing the previous revision v3.2.0.SummaryDifference0.0%

- Check67 days agoChange DetectedThe funding/operating status notice was removed from the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedNew entries for Study Design, Study Status, and Recruitment Status were added, including a Completed status on 2025-10-28 (linked to the 2025-10-27 version). The previous 'Active, not recruiting' status was removed on 2025-07-14.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.